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Abstract
Background: The application of molecular tools to the analysis of tuberculosis has revealed
examples of clonal complexity, such as exogenous reinfection, coinfection, microevolution or
compartmentalization. The detection of clonal heterogeneity by standard genotyping approaches is
laborious and often requires expertise. This restricts the rapid availability of Mycobacterium
tuberculosis  (MTB) genotypes for clinical or therapeutic decision-making. A new PCR-based
technique, MIRU-VNTR, has made it possible to genotype MTB in a time frame close to real-time
fingerprinting. Our purpose was to evaluate the capacity of this technique to provide clinicians with
a rapid discrimination between reactivation and exogenous reinfection and whether MIRU-VNTR
makes it possible to obtain data directly from stored MTB isolates from recurrent episodes.
Results: We detected differences, between the MIRUtypes of recurrent isolates in 38.5% (5/13)
of the cases studied. These included cases of i) exogenous reinfection, often with more resistant
strains, ii) likely examples of microevolution, leading to the appearance of new clonal variants and
iii) a combination of microevolution, coinfection and competition.
Conclusion:  MIRU-VNTR rapidly obtained clinically useful genotyping data in a challenging
situation, directly from stored MTB isolates without subculturing them or purifying their DNA.
Our results also mean that MIRU-VNTR could be applied for easy, rapid and affordable massive
screening of collections of stored MTB isolates, which could establish the real dimension of clonal
heterogeneity in MTB infection.
Background
Until recently, infection by Mycobacterium tuberculosis
(MTB) has been assumed to be clonally simple, and a
tuberculosis (TB) case was traditionally thought to be
infected by a single MTB strain. The introduction of
molecular biology tools into the clinical microbiology
laboratory has shown that this infection is sometimes
clonally complex. In this sense, fingerprinting of clinical
cultures has revealed i) exogenous reinfection as a cause of
recurrences more often than originally thought [1-5], ii)
simultaneous coinfection with different MTB strains [4-7]
iii) microevolution phenomena [8,9] and iv) compart-
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mentalization of the infection, with different strains
infecting different tissues [9,10], or even independent
lung sites [11].
Clonal complexity in TB is now well documented, and cli-
nicians are increasingly requesting characterization of the
strains involved in these cases, mainly to discriminate
between reinfection and reactivation. However, RFLP-
based or spoligotyping-based fingerprinting approaches
do not provide results quickly enough to include MTB
genotypes in the pool of the first-line microbiological data
available to take clinical, therapeutic or epidemiological
decisions.
A new PCR-based fingerprinting technique, MIRU-VNTR
[12], has been considered a suitable alternative for the
simple and rapid detection of clonal complexity in TB
[7,13,14]. We verified whether MIRU-VNTR could pro-
vide a rapid answer in conditions mimicking a real clinical
situation: when MTB is cultured from a patient who had a
previous TB episode and the clinician demands the dis-
crimination between reactivation and exogenous reinfec-
tion. We evaluated the efficiency of MIRU-VNTR for the
rapid analysis of clonal complexity in recurrent cases
directly from a collection of frozen-stored MTB isolates,
without subculturing them or purifying DNA.
Results
We were able to analyze the sequential MTB isolates of 58
patients with two or more recurrent TB episodes (2–5 epi-
sodes separated by intervals of between 6 months and 5
years). Thirty-two stored MTB isolates from 13 represent-
ative cases of recurrences (Table 1) were selected for
MIRU-VNTR genotyping.
We could amplify at least ten of the 12 MIRU targets from
twenty-nine stored clinical isolates (90.6%). In an addi-
tional case we were only able to obtain a fingerprint from
six loci. For the remaining two isolates, no MIRU loci were
amplified (corresponding to two isolates from the years
1997 and 2003) and for one of these, MTB was not recov-
ered after subculture.
Clonal analysis of recurrences
We compared the genotypes of the recurrent isolates
obtained directly from the stored isolates. We found dif-
ferent MIRU types in the recurrent isolates in 5 of the 13
patients (38.5%; cases A, I, J, K, L) and identical MIRU
types were detected for the remaining eight cases (Table 1,
Figures 1 and 2). A highly discriminatory MIRU set of 15
loci was also applied with these eight cases and identical
patterns for the sequential episodes were again obtained
(data not shown). In three of the patients with clonal dif-
ferences the isolates differed in two or more loci, includ-
ing one case whose sequential isolates differed in six loci.
For patients I, J, K, i.e. those with differences in two or
more than two MIRU loci, the RFLP and spoligotyping
analysis confirmed the participation of different MTB
strains (reinfection) in the first and recurrent episodes
(Figure 1). In addition, in two of these cases (I and K) the
susceptibility pattern of the sequential isolates changed
from susceptible to resistant (Figure 1).
In patients L and A, the differences between recurrent iso-
lates were more subtle, and affected only one locus (Fig-
ure 2). RFLP and spoligotype showed identical patterns
for these clonal variants. Therefore we considered that
these cases could be microevolution phenomena and not
true reinfections. Whereas case L was an example of likely
simple microevolution, a much more complex situation
was detected for case A (Figure 2). This patient was ini-
tially infected by a single strain. However, a clonal variant
appeared in the second episode, and continued to coinfect
the patient together with the parental clone. This coinfec-
tion by both clonal variants was detected in the second,
third and fourth episodes and finally, the first variant was
the only one recovered from the fifth episode. In this case
we observed differences in susceptibility patterns for
pyrazinamide in the sequential episodes (Figure 2).
Discussion
The introduction of molecular biology tools in the clinical
setting has revealed that MTB infection is clonally com-
plex and that exogenous reinfection [1-5], simultaneous
coinfection [4-7], compartmentalization [9,10] and
microevolution [8,9] are examples of this clonal complex-
ity.
In the past, clinicians assumed that clonal complexity had
no impact on the management of TB and it was consid-
ered to be merely a refinement of the microbiological
analysis. However, there are reports of TB cases with
clonal complexity in which the strains can differ in their
susceptibility patterns [11,15-17], infectivity [18], or abil-
ity to infect extrarespiratory sites [9,10]. This has alerted
clinicians to the usefulness of accessing to advanced
molecular microbiological analysis.
The procedures usually applied to detect clonal heteroge-
neity are based on low- intensity RFLP bands or on the
analysis of multiple single MTB colonies from culture.
They are cumbersome, require expertise and cannot pro-
vide a quick answer in a real clinical setting. Recently, a
novel genotyping method, MIRU-VNTR [12], has been
proposed as an alternative to simplify and optimize the
detection of clonal complexity directly from culture
[13,19].
In this study, we evaluate the efficiency of MIRU-VNTR at
providing a rapid answer to a frequent request by clini-BMC Microbiology 2007, 7:73 http://www.biomedcentral.com/1471-2180/7/73
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cians, the discrimination between reactivation and exoge-
nous reinfection in recurrent cases. Recurrence is not an
anecdotal aspect of TB, and between 1 and 11% of cases
have a second recurrent episode (7% in our context).
Rapid identification of recurrences caused by exogenous
reinfection could influence therapeutic and epidemiolog-
ical decisions because susceptibility could be different and
the patient should be considered a new case. Besides,
when a case is assumed to be a relapse, rapid information
on exogenous reinfection by a strain spreading in the
community could indicate new recent-transmission
routes and guarantee rigor in the assignation of clusters
indicating ongoing transmission events.
We evaluated the efficiency of MIRU-VNTR in studying
the clonal composition of a selection of recurrent cases by
analyzing our collection of frozen-stored isolates directly,
without subculturing them or purifying DNA for the
molecular study. It is common in the clinical context that
MTB is cultured from a patient who had a previous TB epi-
sode and the isolate from the first episode is available in
the strain-collection of the microbiology department.
However, it is required to subculture the stored isolate
before performing the comparative analysis, which means
a great delay. The design we evaluate offers the possibility
of analyzing stored isolates directly, in order to rapidly
discriminate between reactivation and exogenous reinfec-
tion.
For 29 of the 32 selected isolates we obtained data (in at
least 10 of the 12 loci studied), which shows the high
power of resolution of MIRU-VNTR typing in this chal-
lenging setting. In some cases, certain loci failed to be
amplified directly from the stored isolates, and they could
be amplified from new subcultures; however we have pre-
ferred to show only the results obtained from the direct
amplification of stored isolates. In the case of the two loci
that could not be often amplified (loci 10 and 16), we had
previously observed (data not shown) that they were less
efficiently amplified even with purified DNA samples. A
remarkable feature is that the analysis could be performed
even with isolates stored over a long period (study period:
1990–2006) and most of them were successfully ampli-
fied.
The 13 patients in our study population yielded 5 cases
with some degree of clonal heterogeneity. In three of these
cases (patients I, J, K) changes in two or more loci were
observed between the recurrent isolates, suggesting an
exogenous reinfection with a different strain. These results
were confirmed by the clearly different RFLPtypes and
spoligotypes after subculturing and analyzing the same
isolates. It is worth noting that in two of these three cases,
reinfection was associated with a change in the suscepti-
bility patterns, from a susceptible strain to an INH-resist-
ant strain, which is highly relevant for therapy. The
patients analyzed in this study were different to those
selected in a previous report [5] (33% reinfections) and,
again, the rates of reinfection (23%) were higher than
expected for a context with a moderate incidence of TB.
The good correlation between VNTR-MIRU data and
RFLP/spoligotyping indicated that differences in a small
number of loci (in our case, two) could identify different
strains without requiring standard genotyping analysis. In
Table 1: Characteristics of the patients. IVDU: intravenous drug user







AF e m a l e4 4 9  ( 4 ) + +
B Male 50 IVDU 2 +
CM a l e4 6 4  ( 2 )
D Male 45 HIV+, IVDU, 
Prison
2+
EM a l e 2 8 3 +
F Male 57 Alcoholism 4 (3)
G Male 52 Alcoholism 2 +
H Male 32 HIV+, IVDU 4 +
I Female 31 HIV+, IVDU 2 +
J Male 46 HIV+, IVDU 2 +
K Male 46 HIV+, Alcoholism 2 +
L Male 53 IVDU, Alcoholism, 
Prison
3 (2) +
MM a l e5 3 2
*: The number of episodes with MTB isolates that could be analyzed by MIRU-VNTR are indicated in brackets.BMC Microbiology 2007, 7:73 http://www.biomedcentral.com/1471-2180/7/73
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this sense, a recent study in Shanghai [20] found that dif-
ferences even in only one tandem repeat in a single MIRU
locus enabled the identification of reinfections that were
later confirmed by RFLP.
Although this study analyzed recurrent cases to distin-
guish reinfection from reactivation we found indirectly
that the MIRU-VNTR approach succeeded in detecting
clonal complexity other than reinfection. We identified
another two cases with clonal heterogeneity (patients A
and L) but only subtle differences in one locus were
detected. One of the cases (L) had only 6 bands in the
RFLPtype and it could be a non clonal case [21]. However,
these patients could also be likely examples of microevo-
lutions leading to the appearance of clonal variants more
than examples of reinfections, although appearance of
clonal variants linked to MIRU-VNTR microevolution
events has been found to be rather infrequent in other
studies (2–6% of the clonal cases)[22]. These recurrent
isolates shared identical RFLP and spoligotypes which
suggests that MIRU-VNTR has a higher sensitivity for
detecting subtle genetic differences, although other stud-
ies [14] have shown that MIRU failed to detect subtle dif-
ferences in RFLPtypes. The appearance of clonal variants
in the context of an infection is not usually considered rel-
evant but we report that it could be significant as seen in
a case infected by two clonal variants with high genotypic
similarity but with different infective behaviours; only
one of them was able to infect the CNS whereas the other
was restricted to the respiratory site [9]. The potential dif-
ferential ability to cross the blood-brain barrier between
both coinfecting variants is now being analyzed.
The situation of one of the patients whom clonal variants
were found (case A) was complex, with a likely combina-
tion of microevolution, coinfection and competition.
Here, our results could indicate that from an initial strain
responsible for the first episode, another clonal variant
was originated by genetic drift. The appearance of this sec-
ond clone could be associated with the acquisition of
resistance to pyrazinamide. Both clonal variants coin-
fected the patient over four years and finally, the original
clone competed with the microevolved clone and the
infection recovered its initial clonal homogeneity, with
only the initial clone infecting the patient. However, it
could also be considered that the absence of the second
clone in the last specimen was caused by a sampling effect.
Anyway, this interesting case shows that MTB infection
could be a very dynamic process in clonal terms.
Our sample might be considered too small to enable
clonal heterogeneity to be detected, nevertheless we
detected a high percentage of these cases which suggests
that clonal variability could be detected more frequently
Susceptibility and genotyping features of the isolates from cases with reinfections Figure 1
Susceptibility and genotyping features of the isolates from cases with reinfections. Differences in the MIRUtypes are boxed
_ _ _ _ _ 6 _ 1 3 0 1 0  INH-R, STR-R EPISODE 2
2 2 5 _ 2 5 1 5 4 3 2 1 Susceptible EPISODE 1
Spoligotype RFLP-type MIRU-type Drug susceptibility Episodes
PATIENT
I
1 2 4 3 2 6 1 5 3 3 2 3 Susceptible EPISODE 2
2 2 4 3 2 6 1 5 3 3 2 2  Susceptible EPISODE 1
Spoligotype RFLP-type MIRU-type Drug susceptibility Episodes
PATIENT
J
2 2 3 _ 2 2 1 5 3 3 2 2 INH-R EPISODE 2
2 2 5 _ 1 3 1 5 3 3 2 2 Susceptible EPISODE 1
Spoligotype RFLP-type MIRU-type Drug susceptibility Episodes
PATIENT
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than expected. Moreover, the clonal complexity detected
in this study reveals only a part of the real situation due to
a potential underdetection of clonal heterogeneity caused
by i) the fact that we could not obtain information from
two loci in many cases, ii) the notion that MIRU 12 has
low discriminatory power compared with a recently devel-
oped version with 15 loci [23,24], and iii) the potential
selection of certain MTB clones that could be present in
clinical specimens but that could be counterselected and
masked after culture.
Conclusion
In summary, MIRU-VNTR is an efficient technique for
studying the clonal composition of MTB even in challeng-
ing laboratory circumstances such as the direct analysis of
frozen-stored isolates without subculturing them or puri-
fying DNA. It offers the possibility of rapidly answering
clinical requests for identification of exogenous reinfec-
tion, reactivation or coinfection during the infection of
patients with recurrent TB.
Methods
Patients
We analyzed patients from the general population with
two or more TB episodes (MTB-positive culture) at least
six months apart, during the period 1990–2006. From the
3237 cases with frozen-stored MTB clinical isolates for
that period of time, 58 (1.8%) were recurrent cases. From
these, we selected 13 cases (all autochthonous Spanish
cases) that were representative of a different number of
episodes with different intervals between episodes. All but
one (urine, case J) corresponded to respiratory samples.
Samples
The stored frozen samples contained two loopfuls of MTB
culture suspended in 1.5 ml of storage medium (7H9
Middlebrook 4.7 g/ml, sucrose 5%, glycerin 2%, OADC
10%). The frozen samples had been stored at -70C from
culture until analysis.
MIRU-VNTR typing
DNA was extracted by sonication in a water-bath sonica-
tor (GenProbe) as described elsewhere [25]. Between 500
and 700µl of the stored culture was sonicated for seven
minutes in the presence of 106-micrometers glass beads
(SIGMA). DNA was not purified. 5 microliters of the crude
extract was used for the typing assays by MIRU-VNTR
using the 12-loci format [12]. Amplified products were
run in a 2% MS8 agarose gel (Pronadisa, Madrid, Spain)
for 16.5 hours at 75V to calculate the number of tandem
repeats for each locus.
The potential involvement of laboratory cross-contamina-
tion in the misassigment of genotypes was ruled out by
comparing the genotypes of all the isolates coprocessed
(within a 3-day period) in the laboratory for each of the
samples.
IS6110-RFLP and spoligotyping
For the cases in which MIRUtyping detected genotypic dif-
ferences between the isolates from the recurrent episodes,
Susceptibility and genotyping features from cases with subtle changes in the clonal composition of the isolates Figure 2
Susceptibility and genotyping features from cases with subtle changes in the clonal composition of the isolates. Differences in 





2 2 3 _  2 6 1 5 3 3 2 2 Susceptible EPISODE 2
2 2 3 _  2 6 1 5 3 3 2 3 Susceptible EPISODE 1








2 2 3 5 2   5   1 5 3 3 2 2
2 2 3 5 2 5/6 1 5 3 3 2 2
2 2 3 5 2 5/6 1 5 3 3 2 2
2 2 3 5 2 5/6 1 5 3 3 2 2 
2 2 3 5 2  5   1 5 3 3 2 2
MIRU-type Drug susceptibility Episodes
PATIENT
A
INH-R, RIF-R, PZA-R EPISODE 5
INH-R, RIF-R, PZA-R EPISODE 4
INH-R, RIF-R, PZA-R EPISODE 3
INH-R, RIF-R EPISODE 2
INH-R, RIF-R EPISODE 1BMC Microbiology 2007, 7:73 http://www.biomedcentral.com/1471-2180/7/73
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additional typing by IS6110-RFLP and spoligotyping was
performed. For this purpose, the stored clinical MTB iso-
lates were subcultured in Lowenstein-Jensen slants for
three weeks, DNA was purified from the culture and RFLP
and spoligotyping were performed following standard
procedures [26,27]. Computer-assisted analysis of finger-
prints was carried out using Bionumeric 5.1 software.
Susceptibility test
Susceptibility testing against isoniazid, rifampin, strepto-
mycin, pyrazinamide and ethambutol was performed
using the mycobacterial growth indicator SIRE system
(Becton Dickinson).
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